Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen

Molecular Cancer Research

Volumn 7, Issue 6, 2009, Pages 809-820

  Moss, Natalie M ^a   Liu, Yueying ^c   Johnson, Jeff J ^c   Debiase, Philip ^a   Jones, Jonathan ^a   Hudson, Laurie G ^d   Munshi, Hidayatullah G ^b   Stack, M Sharon ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c University of Missouri   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE 14; TYROSINE;

ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; INTERNALIZATION; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION;

CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; ENDOCYTOSIS; EPIDERMAL GROWTH FACTOR; FEMALE; FLOW CYTOMETRY; HUMANS; MATRIX METALLOPROTEINASE 14; MICROSCOPY, FLUORESCENCE; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE SCAFFOLDS;

EID: 66949151925     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0571     Document Type: Article

References (107)

1. Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1998;265:7709-7712 (Pubitemid 20158927)
2. Wells A. EGF receptor. Int J Biochem Cell Biol 1999;31:637-643 (Pubitemid 29248872)
3. Yarden Y, Sliwkowski MX. Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2001;2:127-137
4. Lafky JM, Wilken JA, Baron AT, Maihle NJ. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 2008;1785:232-265
5. Jorissen RN, Walker F, Pouli N, Garrett T, Ward C, Burgess A. Epidermal growth factor receptor: mechanisms of activation and signaling. Exp Cell Res 2003;284:31-53. (Pubitemid 36331965)
6. Luttrell DK, Luttrell LM, Parsons SJ. Augmented mitogenic responsiveness to Epidermal Growth Factor in murine fibroblasts that overexpress pp6Ocsrc. Mol Cell Biol 1998;8:497-501.
7. Maa MC, Leu TH, McCarley DJ, Schatzman RC, Parsons SJ. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc Natl Acad Sci U S A 1995;92:6981-6985
8. Sakaguchi K, Okabayashi Y, Kido Y, et al. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells. Mol Endocrinol 1998;12:536-543 (Pubitemid 30659084)
9. Hashimoto A, Kurosaki M, Gotoh N, Shibuya M, Kurosaki T. Shc regulates epidermal growth factor-induced activation of the JNK signaling pathway. J Biol Chem 1999;274:20139-20143 (Pubitemid 129519481)
10. David M, Wong L, Flavell R, et al. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem 1996;271:9185-9188 (Pubitemid 26137315)
11. Park OK, Schaefer TS, Nathans D. In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc Natl Acad Sci U S A 1996;93:13704-13708
12. Slaaby R, Jensen T, Hansen HS, Frohman MA, Seedorf K. PLD2 complexes with the EGF receptor and undergoes tyrosine phosphorylation at a single site upon agonist stimulation. J Biol Chem 1998;273:33722-33727 (Pubitemid 29005762)
13. Normanno N, De Luca A, Bianco C, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006;366:2-16. (Pubitemid 43199589)
14. De Luca A, Carotenuto A, Rachiglio A, et al. The role of the EGFR signaling in tumor microenvironment. J Cell Physiol 2008;214:559-567 (Pubitemid 351224199)
15. Ekstrand AJ, James CD, Cavanee WK, Seliger B, Petterson RF, Collins VP. Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 1991;51:2164-2172
16. Blume-Jensen P, Hunter T. Oncogenic kinase signaling. Nature 2001;411:355-365
17. Fox SB, Smith K, Hollyer J, Greenall M, Hastrich D, Harris AL. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res Treat 1999;29:41-49
18. Koenders PG, Beex LV, Kienhuis CB, Kloppenborg PW, Benraad TJ. Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study. Breast Cancer Res Treat 1993;25:21-27 (Pubitemid 23107732)
19. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 2005;3:183-232.
20. See HT, Kavanagh JJ, Hu W, Bast RC. Targeted therapy for epithelial ovarian cancer: current status and future prospects. Int J Gynecol Canc 2003;13:701-734 (Pubitemid 38235215)
21. Berchuck A, Rodriguez GC, Kamel A, et al. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Am J Obstet Gynecol 1991;2:669-674
22. Wang DP, Konishi I, Koshiyama M, et al. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary. Virchows Arch A Pathol Anat Histopathol 1992;421:393-400.
23. Henzen-Logmans SC, van der Burg ME, Foekens JA, et al. Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study. J Cancer Res Clin Oncol 1994;118:303-307
24. Marmor MD, Skaria KB, Yarden Y. Signal transduction and oncogenesis by ErbB/HER receptors. Int J Radiat Oncol Biol Phys 2004;58:903-913 (Pubitemid 38221150)
25. El-Rayes BF, LoRusso PM. Targeting the epidermal growth factor receptor. Br J Cancer 2004;91:418-424 (Pubitemid 39093557)
26. Roskoski R, Jr. The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun 2004;319:1-11.
27. Cowden Dahl KD, Symowicz J, Ning Y, et al. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 2008;68:4606-4613
28. Hudson LG, Zeineldin R, Silberberg M, Stack MS. Activated epidermal growth factor receptor in ovarian cancer. Cancer Treat Res. In press 2009.
29. Crijns APG, Boezen HM, Schouten JP, et al. Prognostic factors in ovarian cancer: current evidence and future prospects. The ECCO 12 Educational Book. Eur J Cancer 2003;1:127-145
30. Alper O, De Santis ML, Stromberg K, Hacker NF, Cho-Chung YS, Salomon DS. Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells. Int J Cancer 2000;88:566-574 (Pubitemid 30805070)
31. Brader KR, Wolf JK, Chakrabarty S, Price JE. Epidermal growth factor receptor (EGFR) antisense transfection reduces the expression of EGFR and suppresses the malignant phenotype of a human ovarian cancer cell line. Oncol Rep 1998;5:1269-1274 (Pubitemid 28372601)
32. Sood AK, Seftor EA, Fletcher MS, et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol 2001;158:1279-1288 (Pubitemid 32281292)
33. Sood AK, Fletcher MS, Coffin JE, et al. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol 2004;190:899-909. (Pubitemid 38561505)
34. Kamat AA, Fletcher M, Gruman LM, et al. The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clin Cancer Res 2006;12:1707-1714
35. Kenny HA, Krausz T, Yamada SD, Lengyel E. Development of an organotypic peritoneal three-dimensional culture to study peritoneal attachment of ovarian cancer cells. Int J Cancer 2001;121:1463-1472
36. Kenny HA, Kaur S, Coussens LM, Lengyel E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008;118:1367-1379
37. Adley BP, Gleason KJ, Yang X, Stack MS. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecol Oncol 2009;112:319-324
38. Ghosh S, Wu Y, Stack MS. Ovarian cancer-associated proteinases. Cancer Treat Res 2002;107:331-351
39. Davidson B, Goldberg I, Gotlieb WH, et al. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastasis 1999;17:799-808. (Pubitemid 30823042)
40. Ellerbroek SM, Hudson LG, Stack MS. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion. Int J Cancer 1998;78:331-337 (Pubitemid 28445371)
41. Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 2001;276:24833-24842 (Pubitemid 33659083)
42. Cowden Dahl KD, Zeineldin R, Hudson LG. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Mol Cancer Res 2007;5:413-421 (Pubitemid 46903950)
43. Afzal S, Lalani EN, Poulsom R, et al. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998;29:155-165 (Pubitemid 28099511)
44. Holmbeck K, Bianco P, Caterina J, et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999;99:81-92. (Pubitemid 29468632)
45. Sabeh F, Ota I, Holmbeck K, et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 2004;167:769-781 (Pubitemid 39565156)
46. Yana I, Seiki M. MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis 2003;19:209-215
47. Zhai Y, Hotary K, Nan B, et al. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res 2005;65:6543-6550 (Pubitemid 41060689)
48. Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006;206:1-8. (Pubitemid 41740711)
49. Kajita M, Itoh Y, Chiba T, et al. Membrane-type I matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001;153:893-904. (Pubitemid 34289231)
50. Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre M, Annabi B, Beliveau R. Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1m atrix metalloproteinase (MT1-MMP). FEBS Lett 2001;507:231-236
51. Barbolina MV, Adley BP, Ariztia EV, Liu Y, Stack MS. Microenvironmental regulation of membrane type 1ma trix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1expression. J Biol Chem 2007;282:4924-4931 (Pubitemid 47100955)
52. Hotary K, Allen E, Punturieri A, Yana I, Weiss S. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 2000;149:1309-1323 (Pubitemid 30399683)
53. Hotary K, Allen E, Brooks P, Datta N, Long M, Weiss SJ. Membrane type 1 matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003;114:33-45. (Pubitemid 36859839)
54. Sato T, Iwai M, Sakai T, Sato H, et al. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Br J Cancer 1999;80:1137-1143 (Pubitemid 29264071)
55. Van Meter TE, Broaddus WC, Rooprai HK, Pilkington GJ, Fillmore HL. Induction of membrane-type-1ma trix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. Neuro oncol 2004;6:188-199 (Pubitemid 39136502)
56. Kheradmand F, Rishi K, Werb Z. Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2. J Cell Sci 2002;115:839-848 (Pubitemid 34196343)
57. Langlois S, Nyalendo C, Di Tomasso G, et al. Membrane-type 1matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation. Mol Cancer Res 2007;5:569-583 (Pubitemid 46985047)
58. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, Pei D. Regulation of membrane-type matrix metalloproteinase 1activity by dynamin mediated endocytosis. Proc Natl Acad Sci U S A 2001;98:13693-13698 (Pubitemid 33115960)
59. Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y. Src-mediated tyrosine phosphorylation of dynamin is required for β2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J Biol Chem 1999;274:1185-1188 (Pubitemid 129507696)
60. Annabi B, Lachambre MP, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R. Localization of membrane-type 1ma trix metalloproteinase in caveolae membrane domains. Biochem J 2001;353:547-553 (Pubitemid 32158323)
61. Puyraimond A, Fridman R, Lemasle M, Arbeille B, Menashi S. MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp Cell Res 2001;262:28-36. (Pubitemid 32989005)
62. Remacle A, Murphy G, Roghi C. Membrane type 1-matrix metalloproteinase (MT1-MMP) is internalized by two different pathways and is recycled to the cell surface. J Cell Sci 2003;116:3905-3916 (Pubitemid 37279306)
63. Ouyang M, Lu S, Li XY, et al. Visualization of polarized membrane type 1 matrix metalloproteinase activity in live cells by fluorescence resonance energy transfer imaging. J Biol Chem 2008;283:17740-17748
64. Smart EJ, Ying YS, Mineo C, Anderson RG. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci U S A 1995;92:10104-10108
65. Mineo C, James GL, Smart EJ, Anderson RG. Localization of epidermal growth factor-stimulated Ras/Raf-1interac tion to caveolae membrane. J Biol Chem 1996;271:11930-11935 (Pubitemid 26157268)
66. Mineo C, Gill GN, Anderson R. Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem 1999;30636-30643 (Pubitemid 129576804)
67. Ning Y, Buranda T, Hudson LG. Activated epidermal growth factor receptor induces integrin α2 internalization via caveolae/raft-dependent endocytic pathway. J Biol Chem 2007;282:6380-6387 (Pubitemid 47100824)
68. Beguinot L, Lyall RM, Willingham MC, Pastan I. Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes. Proc Natl Acad Sci U S A 1984;81:2384-2388 (Pubitemid 14148263)
69. Sorkin A, Waters CM. Endocytosis of growth factor receptors. Bioessays 1993;15:375-382 (Pubitemid 23960864)
70. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenny JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992;68:673-682
71. Ikonen E, Parton RG. Caveolins and cellular cholesterol balance. Traffic 2000;1:212-217
72. Pike LJ, Miller JM. Cholesterol depletion delocalizes phosphatidylinositol biphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. J Biol Chem 1998;273:22298-22304 (Pubitemid 28399788)
73. Gingras D, Michaud M, Tomasso G, Béliveau E, Nyalendo C, Béliveau R. Sphingosine-1-phosphate induces the association of membrane-type 1 matrix metalloproteinase with p130Cas in endothelial cells. FEBS Lett 2008;582:399-404.
74. Nyalendo C, Beaulieu E, Sartelet H, et al. Impaired tyrosine phosphorylation of membrane-type 1matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice. Carcinogenesis 2008;29:1655-1664
75. Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis 2008;25:643-655
76. Moser TL, Pizzo SV, Bafetti LM, Fishman DA, Stack MS. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the α2β1 integrin. Int J Cancer 1996;67:695-701. (Pubitemid 26300989)
77. Tsunezuka Y, Kino H, Takino T, et al. Expression of membrane-type matrix metalloproteinase I (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis. Cancer Res 1996;56:5678-5683 (Pubitemid 26422172)
78. Lisanti MP, Scherer P, Tang ZL, Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell Biol 1994;4:231-235 (Pubitemid 24190653)
79. van Deurs B, Roepstorff K, Hommelgaard AM, Sandvig K. Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 2003;13:92-100. (Pubitemid 36135891)
80. Mineo C, Ying YS, Chapline C, Jaken S, Anderson RG. Targeting of protein kinase C α to caveolae. J Cell Biol 1998;141:601-610 (Pubitemid 28217907)
81. Anderson RGW. The caveolae membrane system. Annu Rev Biochem 1998;67:199-225. (Pubitemid 28411129)
82. Liu P, Rudick M, Anderson RG. Multiple functions of caveolin-1. J Biol Chem 2002;277:41295-41298 (Pubitemid 35257426)
83. Huang CS, Zhou J, Feng AK, et al. Nerve growth factor signaling in caveolae-like domains at the plasma membrane. J Biol Chem 1999;274:36707-36714 (Pubitemid 30005287)
84. Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D, Beliveau R. Src-mediated tyrosine phosphorylation of caveolin-1induces its association with membrane type 1matrix metalloproteinase. Mol Biol Cell 2003;14:334-347
85. Song KS, Shengwen L, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of ras with caveolin, an integral membrane protein of caveolae microdomains. J Biol Chem 1996;271:9690-9697
86. Furuchi T, Anderson RGW. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal related kinase (ERK). J Biol Chem 1998;273:21099-21104 (Pubitemid 28385396)
87. Smart RJ, Graf GA, McNiven MA, et al. Caveolins, liquid ordered domains and signal transduction. Mol Cell Biol 1999;19:7289-7304 (Pubitemid 29493393)
88. Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y. Src-mediated tyrosine phosphorylation of dynamin is required for β2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J Biol Chem 1999;274:1185-1188 (Pubitemid 129507696)
89. Uekita T, Itoh Y, Yana I, Ohno H, Seiki M. Cytoplasmic tail-dependent internalization of membrane type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 2001;155:1345-1356 (Pubitemid 34286282)
90. Le P, Guay G, Altschuler Y, Nabi IR. Caveolin-1is a negative regulator of caveolae mediated endocytosis to the endoplasmic reticulum. J Biol Chem 2002;277:3371-3379 (Pubitemid 34953205)
91. Minshall RD, Tiruppathi C, Vogel SM, et al. Endothelial cell surface gp60 activates vesicle formation and trafficking via G (i)-coupled Src kinase signaling pathway. J Cell Biol 2000;150:1057-1070
92. Thomsen P, Roepstorff K, Stahlhut M, Van Deurs B. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol Biol Cell 2002;13:238-250 (Pubitemid 34106072)
93. Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 2003;4:724-738 (Pubitemid 37361854)
94. Kim YN, Wiepz GJ, Guadarrama AG, Bertics PJ. Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status. J Biol Chem 2000;275:7481-7491 (Pubitemid 30159643)
95. Nyalendo C, Michaud M, Beaulieu E, et al. Src dependent phosphorylation of membrane-type I matrix metallopoteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration. J Biol Chem 2007;282:15690-15699 (Pubitemid 47093303)
96. Nakahara H, Howard L, Thompson E, et al. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci U S A 1997;94:7959-7964 (Pubitemid 27343757)
97. Chen WT, Wang JY. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann N Y Acad Sci 1990;878:361-371 (Pubitemid 29353581)
98. Lehti K, Valtanen H, Wickström SA, Lohi J, Keski-Oja J. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 2000;275:15006-15013 (Pubitemid 30337219)
99. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006;66:3034-3043
100. Wolf K, Wu YI, Liu Y, et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007;9:893-904. (Pubitemid 47190444)
101. Radisky DC, Levy DD, Littlepage LE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005;436:123-127 (Pubitemid 40966197)
102. Lee H, Overall CM, McCulloch CA, Sodek J. A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis. Mol Biol Cell 2006;17:4812-4826 (Pubitemid 44665750)
103. Tam EM, Wu YI, Butler GS, Stack MS, Overall CM. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage. J Biol Chem 2002;277:39005-39014 (Pubitemid 35154767)
104. Itoh Y, Takamura A, Ito N, et al. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 2001;20:4782-4793 (Pubitemid 32848631)
105. Madsen DH, Engelholm LH, Ingvarsen S, et al. Extracellular collagenases and the endocytic receptor, urokinase plasminogen activator receptor-associated protein/endo180, cooperate in fibroblast-mediated collagen degradation. J Biol Chem 2007;282:27037-27045 (Pubitemid 47501939)
106. Wagenaar-Miller RA, Engelholm LH, Gavard J, et al. Complementary roles of intracellular and pericellular collagen degradation pathways in vivo. Mol Cell Biol 2007;27:6309-6322 (Pubitemid 47435739)
107. Wu Y, Munshi HG, Sen R, et al. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem 2004;279:8728-18289 (Pubitemid 38294720)